Abstract 1797: Preclinical evaluation of HM-018, a potent and selective JAK inhibitor in the treatment of myloproliferative disorders
Year: 2012
Type: conference-abstract
Source: Cancer Research
Authors: Yongxin Ren, Wei Deng, Weihua Gu, Wuzhong Shen, Youjun Yu, Xiaoning Yang, Zhixiang Zhang, Shiming Fan, Yang Sai, Jian Wang, James Yan, Jia Li, Helen Zhao, Weiguo Qing, Weiguo Su
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1978720136